Tanning Bed Access and Usage Is Driving Higher Rates of Melanoma in Specific Regions

Melanoma accounts for only 1% of skin cancers in the United States, but results in the largest number of skin cancer deaths. Investigators evaluated the potential link between the availability and use of tanning beds, and the rising rates of melanoma in New England. They found compelling evidence linking tanning bed usage to increased melanoma risk. Their spatial epidemiologic study opens in new tab/window in the Journal of Investigative Dermatology opens in new tab/window, published by Elsevier, provides critical insights to inform public health strategies and reduce melanoma incidence.

The incidence of melanoma in the US has been increasing over the past two decades. Melanoma incidence continues to increase at about 1% each year among females, while it has stabilized in men. Many factors contribute to a region’s incidence of melanoma; the most preventable risk factor is ultraviolet (UV) radiation from both natural sources like solar radiation and artificial sources like tanning beds.

Lead investigator Oliver Wisco, DO, Associate Professor of Dermatology, Warren Alpert Medical School of Brown University and co-first authors Megan M. Tran, Department of Dermatology, Warren Alpert Medical School of Brown University, and Guixing Wei, PhD, Spatial Structures in the Social Sciences, Population Studies and Training Center, Brown University, explain, “Our patients are our primary source of inspiration for this research. Every day, we encounter patients diagnosed with melanoma. Witnessing the devastating impact of this disease drives us to find ways to prevent it. Despite the well-known dangers of UV radiation, access to tanning beds remains widespread, and their usage continues to be prevalent in many regions. This reality compelled us to investigate the potential link between the availability and use of these facilities and the rising rates of melanoma. Our goal was to better understand whether areas with greater access to tanning beds also experience higher rates of melanoma, with the hope that this knowledge could inform more effective public health strategies to combat skin cancer.”

Investigators evaluated the geospatial relationship between melanoma incidence and access to tanning bed facilities at the county level in New England (2014-2018). They obtained melanoma incidence rates, tanning bed facilities locations, and demographic, socioeconomic, and geographic data from the National Cancer Institute State Cancer Profiles, Data Axle, American Community Survey, and United States Geological Survey.

The study revealed a significant association between greater access to tanning bed facilities and increased rates of melanoma in the New England region of the US. Investigators identified six high-risk clusters, seven low-risk clusters, and one outlier of melanoma incidence. Adjusted spatial regression identified that for every one-minute increase in average travel time to tanning facilities within a 30-minute travel time threshold, the melanoma incidence rate decreased by 3.46% in the same county and 1.92% across New England. These results suggest that people in regions with more tanning bed facilities may experience higher incidences of melanoma.

Dr. Wisco notes, “Although we anticipated finding a connection between tanning beds and melanoma, the strength of the association was more pronounced than expected. Our findings add to the growing body of evidence linking tanning bed usage to increased melanoma risk. These results provide critical insights to inform public health strategies aimed at reducing tanning bed use and ultimately, melanoma incidence. We hope to empower individuals to make informed decisions about their skin health and protect themselves from this disease.”

The research team concludes, “Despite growing awareness of skin cancer risks, melanoma continues to be a major public health concern. Our research offers compelling geographic evidence linking access to tanning beds to this deadly disease. The negative association between travel time to tanning facilities and county-level melanoma incidence rate suggests that decreasing access to indoor tanning facilities may help reduce the regional melanoma incidence rate. Future registries should consider capturing data on tanning bed usage to help refine and target melanoma prevention efforts. However, additional research with detailed tanning behavioral data is needed.”

Commenting on the study, noted expert David E. Fisher, MD, PhD, Massachusetts General Hospital (MGH), Harvard Medical School, and Director of the Melanoma Program, MGH Cancer Center and Cutaneous Biology Research Center, MGH, adds: “Melanoma is one of the relatively few human cancers for which a common, preventable cause is well documented: UV radiation. This study helps clarify the linkage between tanning beds and melanoma and helps us focus on how policies aimed at limiting tanning bed use may hopefully further diminish melanoma risk.”

Notes for editors

The article is “A Geospatial Analysis of the Association between Access to Tanning Bed Facilities and Melanoma in the United States New England Region,” by Guixing Wei, PhD, Megan M. Tran, BS, Lauryn Orsillo, BS, Fatima N. Mirza, MD, MPH, Sara Yumeen, MD, Eric Yang, MD, Allison Robbins, MD, Aakash Mehta, Zhijun Liu, Terrence Vance, PhD, John Kawaoka, MD, Abrar A. Qureshi, MD, and Oliver J. Wisco, DO (https://doi.org/10.1016/j.jid.2024.04.038 opens in new tab/window). It appears online in the Journal of Investigative Dermatology, published by Elsevier opens in new tab/window.

The article is openly available for 60 days at https://www.jidonline.org/article/S0022-202X(24)02172-9/fulltext opens in new tab/window.

The full text of the article is also available to credentialed journalists upon request; contact Theresa Monturano at +1 215 239 3711 or [email protected] opens in new tab/window. Journalists wishing to interview the authors should contact Megan M. Tran at [email protected] opens in new tab/window.

About the Journal of Investigative Dermatology

TheJournal of Investigative Dermatology opens in new tab/window (JID) is the official journal of the Society of Investigative Dermatology and the European Society for Dermatological Research. JID publishes high impact reports describing original research related to all aspects of cutaneous biology and skin diseases. Descriptions of important findings that result from basic, translational, or clinical research are published. Clinical research can include, but is not limited to, interventional trials, genetics studies, epidemiology, and health services research. www.jidonline.org opens in new tab/window

About Elsevier

As a global leader in scientific information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies.

We have supported the work of our research and healthcare communities for more than 140 years. Our 9,500 employees around the world, including 2,500 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 2,900 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray’s Anatomy.

Together with the Elsevier Foundation opens in new tab/window, we work in partnership with the communities we serve to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX opens in new tab/window, a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com.